Clinic
Scottsboro Pediatrics PC
Scottsboro Pediatrics PC was paid $4.05M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoSCOTTSBORO PEDIATRICS PC
SCOTTSBORO, AL 35768
SCOTTSBORO, AL 35768
33aNPI1376966416assigned 01/25/2014
33bProvider typePrimary Care Clinic/Center
28Total paid$4.05M
24GClaims117,966
24DCodes billed57
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Alabama
Rank by total paid#3 of 75
Median peer was paid$56K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,646 | $570K | |
| 2019 | 18,810 | $585K | |
| 2020 | 15,686 | $514K | |
| 2021 | 17,733 | $633K | |
| 2022 | 17,274 | $687K | |
| 2023 | 19,103 | $639K | |
| 2024incomplete | 11,714 | $425K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 32,994 | 27,570 | $2.05M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 5,277 | 4,810 | $480K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.4% | 2,525 | 2,257 | $219K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.5% | 14,339 | 12,989 | $182K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.0% | 2,496 | 2,390 | $161K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.9% | 2,445 | 2,338 | $160K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.5% | 2,157 | 2,048 | $140K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.6% | 1,651 | 1,564 | $107K |
| 87449 | 1.7% | 3,047 | 2,847 | $69K | |
| 90686 | 1.2% | 2,541 | 2,514 | $49K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,370 | 1,317 | $36K |
| D1206 | Topical application of fluoride varnish | <1% | 2,145 | 2,045 | $35K |
45 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 388 | $33K |
| 90670 | <1% | 1,782 | $33K | |
| 90648 | <1% | 1,398 | $26K | |
| 90633 | <1% | 1,296 | $24K | |
| 99173 | <1% | 4,887 | $20K | |
| 36416 | <1% | 8,284 | $20K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 450 | $19K |
| 90680 | <1% | 996 | $19K | |
| 83655 | <1% | 1,120 | $16K | |
| 81002 | <1% | 5,306 | $15K | |
| 90723 | <1% | 797 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,464 | $14K |
| 90651 | <1% | 677 | $13K | |
| 87807 | <1% | 1,109 | $11K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 364 | $11K |
| 87430 | <1% | 812 | $8K | |
| 96127 | <1% | 2,089 | $6K | |
| 87634 | <1% | 308 | $6K | |
| 90734 | <1% | 250 | $5K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 468 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 270 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 102 | $4K |
| 90661 | <1% | 156 | $4K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 236 | $4K |
| 90674 | <1% | 193 | $4K | |
| 90672 | <1% | 153 | $3K | |
| 85018 | <1% | 7,245 | $2K | |
| 90619 | <1% | 129 | $2K | |
| 90715 | <1% | 97 | $2K | |
| 86308 | <1% | 346 | $2K | |
| 90696 | <1% | 96 | $2K | |
| 90620 | <1% | 96 | $2K | |
| 90710 | <1% | 91 | $2K | |
| 90716 | <1% | 95 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 43 | $1K |
| 99460 | <1% | 14 | $1K | |
| 90707 | <1% | 60 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 520 | $731.81 |
| 90698 | <1% | 26 | $494.75 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 512 | $461.18 |
| 94664 | <1% | 31 | $260.00 | |
| 90685 | <1% | 13 | $257.27 | |
| 96161 | <1% | 87 | $252.84 | |
| 82947 | <1% | 51 | $184.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 72 | $140.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMJAD, MUHAMMAD (OWNER/PHYSICIAN)